Late-Breaking Clinical Trials V - report from ACC2024

ACC Immediate-Past President Edward T. A. Fry chaired the Late Breaking Clinical Trial V. and shared his insights on the trials: - Coronary Sinus Reducer For The Treatment Of Refractory Angina: A Randomised, Placebo-controlled Trial (ORBITA-COSMIC) - Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement In Patients At Low To Intermediate Risk: One Year Outcomes Of The Randomized DEDICATE-DZHK6 Trial - Effect Of Alcohol-mediated Renal Denervation On Blood Pressure In The Presence Of Antihypertensive Drugs: 3-month Primary Results From The Target Bp I Randomized Trial - Preventive PCI Or Medical Therapy Alone For Atherosclerotic Coronary Vulnerable Plaques - Comparison Of Intravascular Ultrasound-guided Versus Angiography-guided Angioplasty For The Outcomes Of Drug-coated Balloon In The Treatment Of Femoropopliteal Artery Disease Video: https://medicaldigest.org/scientific-contents/interview:late-breaking-clinical-trials-v